Showing results (331-340 of 25,160) with videos related to

Sort By:
Pageof 2,516
Oncotarget|August 18, 2016
Target sequencing and CRISPR/Cas editing reveal simultaneous loss of UTX and UTY in urothelial bladder cancerJinwoo Ahn, Kwang Hyun Kim, Sanghui Park, et al.
Oncotarget|August 18, 2016
Ligand dependent restoration of human TLR3 signaling and death in p53 mutant cellsDaniel Menendez, Julie M Lowe, Joyce Snipe, et al.
Oncotarget|August 18, 2016
Ephrin B3 interacts with multiple EphA receptors and drives migration and invasion in non-small cell lung cancerGhazal Efazat, Metka Novak, Vitaliy O Kaminskyy, et al.
Oncotarget|August 18, 2016
Novel biomarkers of resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virusEric Hastie, Marcela Cataldi, Megan J Moerdyk-Schauwecker, et al.
Oncotarget|August 18, 2016
Doxorubicin-triggered self-assembly of native amphiphilic peptides into spherical nanoparticlesXiaobo Fan, Fengfeng Zhao, Xiyong Wang, et al.
Oncotarget|August 18, 2016
O-mannosylation and N-glycosylation: two coordinated mechanisms regulating the tumour suppressor functions of E-cadherin in cancerSandra Carvalho, Tiago Oliveira, Markus F Bartels, et al.
Oncotarget|August 18, 2016
HGIMDA: Heterogeneous graph inference for miRNA-disease association predictionXing Chen, Chenggang Clarence Yan, Xu Zhang, et al.
Oncotarget|August 18, 2016
Impacts of the mTOR gene polymorphisms rs2536 and rs2295080 on breast cancer risk in the Chinese populationYang Zhao, Yan Diao, XiJing Wang, et al.
Oncotarget|August 18, 2016
Discovery of peptide inhibitors targeting human programmed death 1 (PD-1) receptorQiao Li, Lina Quan, Jiankun Lyu, et al.
Oncotarget|August 18, 2016
MiR-4653-3p and its target gene FRS2 are prognostic biomarkers for hormone receptor positive breast cancer patients receiving tamoxifen as adjuvant endocrine therapyXiaoRong Zhong, GuiQin Xie, Zhang Zhang, et al.
Pageof 2,516